Uriprene
Uriprene is launching a degradable urinary tract stent which will eliminate the need for painful and costly stent removals.
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location Charlotte, NC, USA
- Currency USD
- Founded February 2012
- Employees 1
Company Summary
Uriprene, Inc. is actively engaged in the commercialization of non-vascular stents. Development of the Company’s lead product, a degradable ureteral stent, was initiated in 2006 by Poly-Med, Inc. Uriprene was spun out after all preclinical developments and testing were successfully completed in January 2012.
Team
-
Tanner HargensPresident and CEO
I am an engineer and entrepreneur, taking novel medical devices from concept to market. I received my BS in Biomedical Engineering and MS in Biomaterials. Extending beyond my engineering background, I manage startups and am cross-functionally involved with product development, patent protection, preclinical testing, clinical trials, the regulatory approval process, and early sales.
Previous Investors
-
Poly-Med, Inc.Unconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.